How much is the Pharmaceutical market?

The pharmaceutical market size is estimated to grow at $$ 11200.4 mn in 2024. Read More

What is the growth rate of the Pharmaceutical market?

The growth rate of the pharmaceutical year-over-year is 5%. Read More

Which region held the largest market share in the Pharmaceutical market?

North America is the region to held the largest market share with 100% growth. Read More

Who are the key players in the Pharmaceutical market?

Pfizer, Novartis, Merck, Roche, Johnson & Johnson, AstraZeneca, GSK, Sanofi, AbbVie, Bayer, Eli Lilly, Amgen, Gilead Sciences, Bristol-Myers Squibb, Teva Pharmaceutical, Apotex, Mylan, Viatris, Sun Pharma, .... Read More

Which Segment has the largest market share in the Pharmaceutical market?

Distribution Channel is the segment that has the largest market share in the market. Read More

Canada Pharmaceutical Market Analysis, Size, and Forecast 2025-2029

Published: Mar 2025
Pages: 211
SKU: IRTNTR77771

Enjoy complimentary customisation on priority with our Enterprise License!

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Country Market Characteristics
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Therapy Area
- Executive Summary - Chart on Market Segmentation by Age Group
- Executive Summary - Chart on Market Segmentation by Product Type
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation

2.3 Factors of disruption
- Overview on factors of disruption

2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market

3.2 Market characteristics
- Market characteristics analysis

3.3 Value chain analysis
- Value chain analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition

4.2 Market segment analysis
- Market segments

4.3 Market size 2024

4.4 Market outlook: Forecast for 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada: Year-over-year growth 2024-2029 (%)
- Data Table on Canada: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Pharmaceutical Market in Canada 2019 - 2023
- Historic Market Size - Data Table on Pharmaceutical Market in Canada 2019 - 2023 ($ million)

5.2 Distribution Channel segment analysis 2019 - 2023
- Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)

5.3 Type segment analysis 2019 - 2023
- Historic Market Size - Type Segment 2019 - 2023 ($ million)

5.4 Therapy Area segment analysis 2019 - 2023
- Historic Market Size - Therapy Area Segment 2019 - 2023 ($ million)

5.5 Age Group segment analysis 2019 - 2023
- Historic Market Size - Age Group Segment 2019 - 2023 ($ million)

5.6 Product Type segment analysis 2019 - 2023
- Historic Market Size - Product Type Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

6.1 Impact of AI on the Pharmaceutical Market in Canada

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029

7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029

7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029

7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029

7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029

7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029

7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Distribution Channel

8.1 Market segments
- Chart on Distribution Channel - Market share (2024-2029) (%)
- Data Table on Distribution Channel - Market share (2024-2029) (%)

8.2 Comparison by Distribution Channel
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel

8.3 Retail pharmacies - Market size and forecast (2024-2029)
- Chart on Retail pharmacies - Market size and forecast (2024-2029) ($ million)
- Data Table on Retail pharmacies - Market size and forecast (2024-2029) ($ million)
- Chart on Retail pharmacies - Year-over-year growth (2024-2029) (%)
- Data Table on Retail pharmacies - Year-over-year growth (2024-2029) (%)

8.4 Hospital pharmacies - Market size and forecast (2024-2029)
- Chart on Hospital pharmacies - Market size and forecast (2024-2029) ($ million)
- Data Table on Hospital pharmacies - Market size and forecast (2024-2029) ($ million)
- Chart on Hospital pharmacies - Year-over-year growth (2024-2029) (%)
- Data Table on Hospital pharmacies - Year-over-year growth (2024-2029) (%)

8.5 Online pharmacies - Market size and forecast (2024-2029)
- Chart on Online pharmacies - Market size and forecast (2024-2029) ($ million)
- Data Table on Online pharmacies - Market size and forecast (2024-2029) ($ million)
- Chart on Online pharmacies - Year-over-year growth (2024-2029) (%)
- Data Table on Online pharmacies - Year-over-year growth (2024-2029) (%)

8.6 Clinics - Market size and forecast (2024-2029)
- Chart on Clinics - Market size and forecast (2024-2029) ($ million)
- Data Table on Clinics - Market size and forecast (2024-2029) ($ million)
- Chart on Clinics - Year-over-year growth (2024-2029) (%)
- Data Table on Clinics - Year-over-year growth (2024-2029) (%)

8.7 Direct-to-consumer - Market size and forecast (2024-2029)
- Chart on Direct-to-consumer - Market size and forecast (2024-2029) ($ million)
- Data Table on Direct-to-consumer - Market size and forecast (2024-2029) ($ million)
- Chart on Direct-to-consumer - Year-over-year growth (2024-2029) (%)
- Data Table on Direct-to-consumer - Year-over-year growth (2024-2029) (%)

8.8 Market opportunity by Distribution Channel
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)

9 Market Segmentation by Type

9.1 Market segments
- Chart on Type - Market share (2024-2029) (%)
- Data Table on Type - Market share (2024-2029) (%)

9.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type

9.3 Prescription - Market size and forecast (2024-2029)
- Chart on Prescription - Market size and forecast (2024-2029) ($ million)
- Data Table on Prescription - Market size and forecast (2024-2029) ($ million)
- Chart on Prescription - Year-over-year growth (2024-2029) (%)
- Data Table on Prescription - Year-over-year growth (2024-2029) (%)

9.4 Non-prescription - Market size and forecast (2024-2029)
- Chart on Non-prescription - Market size and forecast (2024-2029) ($ million)
- Data Table on Non-prescription - Market size and forecast (2024-2029) ($ million)
- Chart on Non-prescription - Year-over-year growth (2024-2029) (%)
- Data Table on Non-prescription - Year-over-year growth (2024-2029) (%)

9.5 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)

10 Market Segmentation by Therapy Area

10.1 Market segments
- Chart on Therapy Area - Market share (2024-2029) (%)
- Data Table on Therapy Area - Market share (2024-2029) (%)

10.2 Comparison by Therapy Area
- Chart on Comparison by Therapy Area
- Data Table on Comparison by Therapy Area

10.3 Oncology - Market size and forecast (2024-2029)
- Chart on Oncology - Market size and forecast (2024-2029) ($ million)
- Data Table on Oncology - Market size and forecast (2024-2029) ($ million)
- Chart on Oncology - Year-over-year growth (2024-2029) (%)
- Data Table on Oncology - Year-over-year growth (2024-2029) (%)

10.4 Cardiovascular - Market size and forecast (2024-2029)
- Chart on Cardiovascular - Market size and forecast (2024-2029) ($ million)
- Data Table on Cardiovascular - Market size and forecast (2024-2029) ($ million)
- Chart on Cardiovascular - Year-over-year growth (2024-2029) (%)
- Data Table on Cardiovascular - Year-over-year growth (2024-2029) (%)

10.5 Neurology - Market size and forecast (2024-2029)
- Chart on Neurology - Market size and forecast (2024-2029) ($ million)
- Data Table on Neurology - Market size and forecast (2024-2029) ($ million)
- Chart on Neurology - Year-over-year growth (2024-2029) (%)
- Data Table on Neurology - Year-over-year growth (2024-2029) (%)

10.6 Endocrinology - Market size and forecast (2024-2029)
- Chart on Endocrinology - Market size and forecast (2024-2029) ($ million)
- Data Table on Endocrinology - Market size and forecast (2024-2029) ($ million)
- Chart on Endocrinology - Year-over-year growth (2024-2029) (%)
- Data Table on Endocrinology - Year-over-year growth (2024-2029) (%)

10.7 Others - Market size and forecast (2024-2029)
- Chart on Others - Market size and forecast (2024-2029) ($ million)
- Data Table on Others - Market size and forecast (2024-2029) ($ million)
- Chart on Others - Year-over-year growth (2024-2029) (%)
- Data Table on Others - Year-over-year growth (2024-2029) (%)

10.8 Market opportunity by Therapy Area
- Market opportunity by Therapy Area ($ million)
- Data Table on Market opportunity by Therapy Area ($ million)

11 Market Segmentation by Age Group

11.1 Market segments
- Chart on Age Group - Market share (2024-2029) (%)
- Data Table on Age Group - Market share (2024-2029) (%)

11.2 Comparison by Age Group
- Chart on Comparison by Age Group
- Data Table on Comparison by Age Group

11.3 Adults - Market size and forecast (2024-2029)
- Chart on Adults - Market size and forecast (2024-2029) ($ million)
- Data Table on Adults - Market size and forecast (2024-2029) ($ million)
- Chart on Adults - Year-over-year growth (2024-2029) (%)
- Data Table on Adults - Year-over-year growth (2024-2029) (%)

11.4 Children and adolescents - Market size and forecast (2024-2029)
- Chart on Children and adolescents - Market size and forecast (2024-2029) ($ million)
- Data Table on Children and adolescents - Market size and forecast (2024-2029) ($ million)
- Chart on Children and adolescents - Year-over-year growth (2024-2029) (%)
- Data Table on Children and adolescents - Year-over-year growth (2024-2029) (%)

11.5 Geriatric - Market size and forecast (2024-2029)
- Chart on Geriatric - Market size and forecast (2024-2029) ($ million)
- Data Table on Geriatric - Market size and forecast (2024-2029) ($ million)
- Chart on Geriatric - Year-over-year growth (2024-2029) (%)
- Data Table on Geriatric - Year-over-year growth (2024-2029) (%)

11.6 Market opportunity by Age Group
- Market opportunity by Age Group ($ million)
- Data Table on Market opportunity by Age Group ($ million)

12 Market Segmentation by Product Type

12.1 Market segments
- Chart on Product Type - Market share (2024-2029) (%)
- Data Table on Product Type - Market share (2024-2029) (%)

12.2 Comparison by Product Type
- Chart on Comparison by Product Type
- Data Table on Comparison by Product Type

12.3 Oral drugs - Market size and forecast (2024-2029)
- Chart on Oral drugs - Market size and forecast (2024-2029) ($ million)
- Data Table on Oral drugs - Market size and forecast (2024-2029) ($ million)
- Chart on Oral drugs - Year-over-year growth (2024-2029) (%)
- Data Table on Oral drugs - Year-over-year growth (2024-2029) (%)

12.4 Injectables - Market size and forecast (2024-2029)
- Chart on Injectables - Market size and forecast (2024-2029) ($ million)
- Data Table on Injectables - Market size and forecast (2024-2029) ($ million)
- Chart on Injectables - Year-over-year growth (2024-2029) (%)
- Data Table on Injectables - Year-over-year growth (2024-2029) (%)

12.5 Topical drugs - Market size and forecast (2024-2029)
- Chart on Topical drugs - Market size and forecast (2024-2029) ($ million)
- Data Table on Topical drugs - Market size and forecast (2024-2029) ($ million)
- Chart on Topical drugs - Year-over-year growth (2024-2029) (%)
- Data Table on Topical drugs - Year-over-year growth (2024-2029) (%)

12.6 Inhalation drugs - Market size and forecast (2024-2029)
- Chart on Inhalation drugs - Market size and forecast (2024-2029) ($ million)
- Data Table on Inhalation drugs - Market size and forecast (2024-2029) ($ million)
- Chart on Inhalation drugs - Year-over-year growth (2024-2029) (%)
- Data Table on Inhalation drugs - Year-over-year growth (2024-2029) (%)

12.7 Others - Market size and forecast (2024-2029)
- Chart on Others - Market size and forecast (2024-2029) ($ million)
- Data Table on Others - Market size and forecast (2024-2029) ($ million)
- Chart on Others - Year-over-year growth (2024-2029) (%)
- Data Table on Others - Year-over-year growth (2024-2029) (%)

12.8 Market opportunity by Product Type
- Market opportunity by Product Type ($ million)
- Data Table on Market opportunity by Product Type ($ million)

13 Customer Landscape

13.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

14 Drivers, Challenges, and Opportunity/Restraints

14.1 Market drivers

14.2 Market challenges

14.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

14.4 Market opportunities/restraints

15 Competitive Landscape

15.1 Overview

15.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation

15.3 Landscape disruption
- Overview on factors of disruption

15.4 Industry risks
- Impact of key risks on business

16 Competitive Analysis

16.1 Companies profiled
- Companies covered

16.2 Market positioning of companies
- Matrix on companies position and classification

16.3 Pfizer
- Pfizer - Overview
- Pfizer - Product / Service
- Pfizer - Key offerings

16.4 Novartis
- Novartis - Overview
- Novartis - Product / Service
- Novartis - Key offerings

16.5 Merck
- Merck - Overview
- Merck - Product / Service
- Merck - Key offerings

16.6 Roche
- Roche - Overview
- Roche - Product / Service
- Roche - Key offerings

16.7 Johnson & Johnson
- Johnson & Johnson - Overview
- Johnson & Johnson - Product / Service
- Johnson & Johnson - Key offerings

16.8 AstraZeneca
- AstraZeneca - Overview
- AstraZeneca - Product / Service
- AstraZeneca - Key offerings

16.9 GSK
- GSK - Overview
- GSK - Product / Service
- GSK - Key offerings

16.10 Sanofi
- Sanofi - Overview
- Sanofi - Product / Service
- Sanofi - Key offerings

16.11 AbbVie
- AbbVie - Overview
- AbbVie - Product / Service
- AbbVie - Key offerings

16.12 Bayer
- Bayer - Overview
- Bayer - Product / Service
- Bayer - Key offerings

16.13 Eli Lilly
- Eli Lilly - Overview
- Eli Lilly - Product / Service
- Eli Lilly - Key offerings

16.14 Amgen
- Amgen - Overview
- Amgen - Product / Service
- Amgen - Key offerings

16.15 Gilead Sciences
- Gilead Sciences - Overview
- Gilead Sciences - Product / Service
- Gilead Sciences - Key offerings

16.16 Bristol-Myers Squibb
- Bristol-Myers Squibb - Overview
- Bristol-Myers Squibb - Product / Service
- Bristol-Myers Squibb - Key offerings

16.17 Teva Pharmaceutical
- Teva Pharmaceutical - Overview
- Teva Pharmaceutical - Product / Service
- Teva Pharmaceutical - Key offerings

16.18 Apotex
- Apotex - Overview
- Apotex - Product / Service
- Apotex - Key offerings

16.19 Mylan
- Mylan - Overview
- Mylan - Product / Service
- Mylan - Key offerings

16.20 Viatris
- Viatris - Overview
- Viatris - Product / Service
- Viatris - Key offerings

16.21 Sun Pharma
- Sun Pharma - Overview
- Sun Pharma - Product / Service
- Sun Pharma - Key offerings

16.22 Cipla
- Cipla - Overview
- Cipla - Product / Service
- Cipla - Key offerings

16.23 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Product / Service
- Abbott Laboratories - Key offerings

16.24 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key offerings

16.25 Amgen Inc.
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key offerings

16.26 Apotex Inc.
- Apotex Inc. - Overview
- Apotex Inc. - Product / Service
- Apotex Inc. - Key offerings

16.27 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key offerings

16.28 Bayer AG
- Bayer AG - Overview
- Bayer AG - Product / Service
- Bayer AG - Key offerings

16.29 Boehringer Ingelheim International GmbH
- Boehringer Ingelheim International GmbH - Overview
- Boehringer Ingelheim International GmbH - Product / Service
- Boehringer Ingelheim International GmbH - Key offerings

16.30 Bristol Myers Squibb Co.
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key offerings

16.31 Eli Lilly and Co.
- Eli Lilly and Co. - Overview
- Eli Lilly and Co. - Product / Service
- Eli Lilly and Co. - Key offerings

16.32 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Product / Service
- F. Hoffmann La Roche Ltd. - Key offerings

16.33 Gilead Sciences Inc.
- Gilead Sciences Inc. - Overview
- Gilead Sciences Inc. - Product / Service
- Gilead Sciences Inc. - Key offerings

16.34 GlaxoSmithKline Plc
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Product / Service
- GlaxoSmithKline Plc - Key offerings

16.35 Johnson and Johnson Services Inc.
- Johnson and Johnson Services Inc. - Overview
- Johnson and Johnson Services Inc. - Product / Service
- Johnson and Johnson Services Inc. - Key offerings

16.36 Les Laboratoires Servier
- Les Laboratoires Servier - Overview
- Les Laboratoires Servier - Product / Service
- Les Laboratoires Servier - Key offerings

16.37 Merck and Co. Inc.
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Product / Service
- Merck and Co. Inc. - Key offerings

16.38 Novartis AG
- Novartis AG - Overview
- Novartis AG - Product / Service
- Novartis AG - Key offerings

16.39 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key offerings

16.40 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Product / Service
- Sanofi SA - Key offerings

16.41 Sun Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd. - Overview
- Sun Pharmaceutical Industries Ltd. - Product / Service
- Sun Pharmaceutical Industries Ltd. - Key offerings

16.42 Teva Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd. - Overview
- Teva Pharmaceutical Industries Ltd. - Product / Service
- Teva Pharmaceutical Industries Ltd. - Key offerings

17 Appendix

17.1 Scope of the report

17.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist

17.3 Currency conversion rates for US$
- Currency conversion rates for US$

17.4 Research methodology
- Research methodology

17.5 Data procurement
- Information sources

17.6 Data validation
- Data validation

17.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing

17.8 Data synthesis
- Data synthesis

17.9 360 degree market analysis
- 360 degree market analysis

17.10 List of abbreviations
- List of abbreviations

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES